• Supplementary Discussion Supplementary Data Fig. 1 : Conventionalization of GF SERT +/mice results in enrichment of spore-forming bacteria of the gut microbiota. a, Fecal 5-HT levels from conventionalized (conv) WT vs. SERT +/-(HET) mice relative to GF controls (one-way ANOVA with Bonferroni, n=16, 12, 8, 6 mice). b, Principal coordinate analysis of 16S rDNA sequencing data of feces from WT vs. SERT HET mice at 1 day and 35 days after conventionalization (n=6 cages). c, Alphadiversity of OTUs from 16S rDNA sequencing of feces from WT vs SERT HET mice at 1 day and 35 days after conventionalization (two-way ANOVA with Bonferroni, n=6 cages). d, Taxonomic diversity of the fecal microbiota from WT vs SERT HET mice at 1 day and 35 days after conventionalization (n=6 cages). e, Relative abundance of bacterial taxa in fecal microbiota from WT vs SERT HET mice at 1 day and 35 days after conventionalization (one-way ANOVA with Kruskal-Wallis, n=6 cages). f, Pathway analysis of inferred metagenomes generated by PICRUSt analysis of 16S rDNA sequencing data from WT vs SERT HET mice at 35 days after conventionalization (n=6 cages). g, Inferred gene content for neurotransmitter sodium symporter (NSS) related proteins calculated by PICRUSt analysis of 16S rDNA sequencing data from WT vs SERT HET mice at 35 days after conventionalization (one-way ANOVA with Kruskal-Wallis,
c n=6 cages). (Mean ± SEM, * p < 0.05, *** p < 0.001, **** p < 0.0001, n.s. = not statistically significant; refer to Supplementary Table 11 for detailed statistical information) Supplementary Data Fig. 2 : Homology of Turicibacter sanguinis putative serotonin transporter to human SERT. a, BLASTP alignment scores between human (h) SERT with other mammalian biogenic amine transporters, Turicibacter orthologs and bacterial amino acid transporter, LeuT. b, Unrooted phylogenetic tree of top 15 bacterial orthologs to hSERT. Fig. 3 : Structural modeling of CUW_0748 from Turicibacter sanguinis strain MOL361. a, Sequence alignment of CUW_0748 (turiSERT) and the template, thermostabilized human (h) SERT (PDB code 5i6x). Black rectangles indicate areas where refinements were made relative to the initial AlignMe PST pair-wise alignment. Background colors indicate residue type: acidic (red), basic (dark blue), polar (cyan), hydrophobic or aromatic (white), glycine and proline (gray), and histidine (light green). b, Average per-residue ProQM scores of 500 models obtained after refining the sequence alignment (cyan line) and their standard deviation (blue shaded region). Global ProQM score before refinement: 0.83, after refinement: 0.86; ProQM score of truncated X-ray structure template (5i6x): 0.83 (black line). MolProbity score of final model: 1.45 Å, on par with the score of the template (5i6x chain A; 2.2 Å), and there were no residues in the generously-allowed or disallowed residues of the Ramachandran plot. c, Template and structural model viewed from within plane of the membrane, highlighting segments that are only present in template (dark gray), and segments where alignment was refined (pink). These adjustments were only found to be necessary in loop regions or at the ends of transmembrane helices. Bound ligands include paroxetine (orange sticks), Na + (blue) and Clions (green). The ion at the Na2 site is taken from another structure of hSERT, 5i71, and its position was obtained by superposing the backbone of the Na2-site residues onto the equivalent region in 5i6x. Fig. 4 : Growth curve of Turicibacter sanguinis MOL361 in Schaedler broth supplemented with 5-HT and/or fluoxetine. Cell density of T. sanguinis at 6, 12, 18, 30, 36, 45 and 48 hours of growth in the presence of 200 uM 5-HT, fluoxetine (Flx) or both 5-HT and Flx. Treatments were added at the start of culture (e.g. t = 0 h). (two-way ANOVA with Bonferroni, n=3 cultures) (Mean ± SEM, **** p < 0.0001; refer to Supplementary Table 11 for detailed statistical information) Fig. 6 : Heterologous expression of CUW_0748 from Turicibacter sanguinis in Bacteroides thetaiotaomicron. a, Representative image of imported APP+ (green) in wildtype T. sanguinis versus B. thetaiotaomicron (B. theta) as measured by the APP+ uptake assay (representative of at least 3 experiments). b, PCR amplification of the CUW_0748 gene in B. theta clones harboring the CUW_0748 insert compared to vector control (pFD340) (representative of at least 3 experiments). c, qPCR for CUW_0748 mRNA expression in B. theta clones harboring the CUW_0748 insert compared to the vector control (pFD340) (two-tailed unpaired Student's t-test, n=3 cultures). d, Kinetics of [ 3 H]5-HT uptake by CUW_0748, as measured as the difference in [ 3 H]5-HT import between B. theta expressing CUW_0748 and the vector control (pFD340) at 5, 10, 20 and 60 min of incubation with 1 uM [ 3 H]5-HT. n=4, 10, 7, 13, 3 biologically independent samples per time point. e, Dose-dependent [ 3 H]5-HT uptake by CUW_0748, as measured as the difference in [ 3 H]5-HT import between B. theta expressing CUW_0748 and the vector control (pFD340) at 1-400 uM [ 3 H]5- HT. n=8, 9, 9, 9, 9 biologically Supplementary Table 11 for detailed statistical information). Fig. 7 : Effects of 5-HT and fluoxetine on T. sanguinis colonization in the colon from antibiotic-treated mice. a, Representative FISH images of T. sanguinis (green), intestinal epithelial cells (DAPI, blue) and bacteria stained with the eubacterial probe EUB338 (red) in colons from antibiotic-treated mice gavaged with T. sanguinis pre-treated for 4 hr with vehicle, 200 uM 5-HT, or 200 uM 5-HT with Flx (n=9). Scale bar denotes 100 um. b, Relative abundance of Turicibacter measured by 16S rDNA sequencing of colonic lumenal contents harvested from antibiotic-treated mice colonized with T. sanguinis pre-treated for 4 hr with vehicle, 200 uM 5-HT, or 200 uM 5-HT with Flx (one-way ANOVA with Bonferroni, n=9). (Mean ± SEM, ** p < 0.01; refer to Supplementary Table 11 for detailed statistical information) Supplementary Table 11 for detailed statistical information). Fig. 12 : Effects of fluoxetine treatment on the fecal microbiota of SPF mice. a, Fecal levels of 5-HT after oral gavage with 10 mg/kg fluoxetine (Flx) daily for 7 days or fluoxetine treatment in drinking water (40 µg/ml) for 2 weeks (two-tailed unpaired Student's ttest, n=14 mice). b, Alpha-diversity of the fecal microbiota after Flx vs. vehicle (veh) treatment (n=18 cages). c, Relative abundance of significantly altered bacterial taxa (two-way ANOVA with Kruskal Wallis, n=18 cages). (Mean ± SEM, * p < 0.05, ** p < 0.01; refer to Supplementary Table  11 for detailed statistical information). Bolded numbers represent total differentially expressed genes. Numbers in green denote upregulated genes; numbers in red denote downregulated genes. Numbers in parentheses denote subsets of T. sanguinis-regulated genes that were further differentially expressed by SPF (n=5, 5, 4 mice). b, GO term enrichment analysis of genes differentially expressed in colon in response to T. sanguinis relative to GF vs SPF controls (Fisher exact, n=5, 5, 4) . c, Heatmap of the 87 genes that are differentially expressed genes by colon in response to T. sanguinis colonization (n=5, 5, 4). 20 10 (0,10) 10 (10,0) Supplementary Table  11 for detailed statistical information). 
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Supplementary Discussion:
We identify and characterize the function of a putative bacterial neurotransmitter sodium symporter (NSS) expressed by Turicibacter sanguinis, which displays considerable sequence and structural homology to the mammalian serotonin transporter (SERT). Consistent with the role of SERT, T. sanguinis uptakes 5-HT, which is partially inhibited by the selective serotonin reuptake inhibitor (SSRI) fluoxetine. Uptake of 5-HT is associated with reduced expression of genes encoding membrane solute transporters and sporulation factors. Treatment of T. sanguinis with fluoxetine reduces 5-HT uptake, reverses a subset of 5-HT-induced gene expression changes and significantly limits intestinal colonization. Recent microbiota profiling studies in human cohorts demonstrated that psychotrophic drugs significantly alter the composition of the gut microbiota 63-65 . However, whether these compounds mediate microbiota changes through direct interactions with bacteria or indirect host responses remains unknown. In our study, we interrogate and identify direct effects of fluoxetine on the physiology of a gut bacterium and its ability to colonize the host gastrointestinal tract.
We find that 5-HT and fluoxetine regulate bacterial 5-HT import, gene expression and competitive colonization of T. sanguinis. While T. sanguinis treated with 5-HT is able to persistently colonize intestinal tracts of antibiotic-treated mice, co-treatment of T. sanguinis with fluoxetine reduced levels of colonized bacteria detected 1-7 days after initial colonization. Notably, we observed that the severity of fluoxetine-induced reductions in T. sanguinis colonization may vary depending on the competing bacterial taxon that enriches most highly after colonization. In 4 out of 6 competitive colonization experiments, T. sanguinis treated with fluoxetine exhibited substantially reduced competitive colonization ability when the dominant colonizing taxon was Akkermansia, Blautia, Enterococcus or Lactobacillus; however in 2 experiments, T. sanguinis treated with fluoxetine maintained colonization ability when the second dominant taxon was Clostridiaceae. This is interesting in light of our findings that relative abundances of both T. sanguinis and Clostridiaceae co-vary and increase in response to elevations in host 5-HT. Additional studies are needed to fully examine the mechanisms underlying fluoxetine-induced impairments in T. sanguinis colonization, and to further explore the nature of microbe-microbe interactions between T. sanguinis and different bacterial species from the gut microbiome.
Previous reports revealed species-and dose-dependent antimicrobial effects of some SSRIs including fluoxetine, paroxetine and sertraline 66 . Possible mechanisms of SSRI antimicrobial activity are largely unclear but may involve inhibition of bacterial multidrug efflux pumps 67 .
Fluoxetine inhibits the growth of T. sanguinis but does not significantly alter bacterial viability when added to a grown batch culture or when administered to monocolonized mice. In addition, fluoxetine has little effect on T. sanguinis gene expression in the absence 5-HT, and fluoxetine impairs the ability of T. sanguinis to competitively colonize in microbiota-depleted mice, but not its ability to monocolonize germ-free mice. Therefore, we believe there are direct effects of fluoxetine on Turicibacter that are mediated by 5-HT modulation, rather than any cytostatic, antimicrobial or off-target effects, but we do not exclude the possibility there may be additional effects of varied fluoxetine concentrations or treatment regimens on Turicibacter that modulate 5-HT uptake and intestinal colonization. Notably, paroxetine also inhibited growth of T. sanguinis and had no effect on viability when added to grown batch cultures. However, in a pilot experiment, pre-treatment of T. sanguinis with paroxetine, instead of fluoxetine, had no effect on its ability to colonize antibiotic-treated mice when examined 3 days later. This suggests that the
